Envisioning an improved research strategy for detecting moderators/mediators in intervention studies: A commentary on McClure et al. HC Kraemer International Journal of Eating Disorders, 2024 | | 2024 |
Cognitive markers for efficacy of neurofeedback for attention-deficit hyperactivity disorder–personalized medicine using computational psychiatry in a randomized clinical trial NR Ging-Jehli, HC Kraemer, L Eugene Arnold, ME Roley-Roberts, ... Journal of clinical and experimental neuropsychology 45 (2), 118-131, 2023 | 3 | 2023 |
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents CU Correll, M Solmi, S Cortese, M Fava, M Højlund, HC Kraemer, ... World Psychiatry 22 (1), 48-74, 2023 | 55 | 2023 |
Caution warranted when interpreting registry studies of medication. A response to Boland et al.(2020) J Cotton, JM Swanson, E Sonuga-Barke, HC Kraemer Journal of psychiatric research 150, 279-281, 2022 | 1 | 2022 |
30.4 UNDERLYING COGNITIVE COMPONENTS RESPOND TO NEUROFEEDBACK FOR ADHD AND MODERATE CLINICAL OUTCOME N Ging-Jehli, LE Arnold, R deBeus, M Roley-Roberts, H Kraemer Journal of the American Academy of Child and Adolescent Psychiatry 60 (10 …, 2021 | | 2021 |
" Rules" of evidence in assessing the efficacy and effectiveness of treatments HC Kraemer The Biological and Social Determinants of Child Development, 705-718, 2020 | 22 | 2020 |
Common types of gender-based microaggressions in medicine VS Periyakoil, L Chaudron, EV Hill, V Pellegrini, E Neri, HC Kraemer Academic Medicine 95 (3), 450-457, 2020 | 79 | 2020 |
Wrangling with p‐values versus effect sizes to improve medical decision‐making: A tutorial HC Kraemer, E Neri, D Spiegel International Journal of Eating Disorders 53 (2), 302-308, 2020 | 16 | 2020 |
A Comment on “Beyond P-value: the Rigor and Power of Study” H Kraemer Glob Clin Transl Res 2 (1), 7-9, 2020 | 4 | 2020 |
Mutations in sphingolipid metabolism genes are associated with ADHD HH Marcela, MT Acosta, AF Martinez, JI Vélez, F Lopera, D Pineda, ... Translational Psychiatry 10 (1), 2020 | | 2020 |
Is it time to ban the P value? HC Kraemer JAMA psychiatry 76 (12), 1219-1220, 2019 | 62 | 2019 |
Effect of Suppressed Emotions on Health—Homoeopathic Aspect RS Bawaskar, VH Shinde Homœopathic Links 32 (03), 141-144, 2019 | | 2019 |
Doing right by your patients HC Kraemer, VS Periyakoil Evidence-based practice in action: Bridging clinical science and …, 2019 | 2 | 2019 |
When meta-analyses get it wrong: response to ‘treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized controlled trials’ J Lock, HC Kraemer, B Jo, J Couturier Psychological Medicine 49 (4), 697-698, 2019 | 14 | 2019 |
Measuring test-retest reliability: The intraclass kappa DG Fisher, GL Reynolds, E Neri, A Noda, HC Kraemer SAS Conf. Proc, 2019 | 8 | 2019 |
“Not just another meta‐analysis”: Sources of heterogeneity in psychosocial treatment effect on cancer survival S Mirosevic, B Jo, HC Kraemer, M Ershadi, E Neri, D Spiegel Cancer medicine 8 (1), 363-373, 2019 | 51 | 2019 |
A three-step letter advance directive procedure to facilitate patient-proxy alignment in advance care planning M Alagappan, MT Richardson, MK Schoen, L Muffly, K Tierney, P Jenkins, ... Journal of Palliative Medicine 21 (12), 1749-1754, 2018 | 7 | 2018 |
Outcomes of Double-Blind Randomized Clinical Trial of Neurofeedback for ADHD LE Arnold, C Kerson, V Monastra, J Pan, H Kraemer, R Rice, JA Barterian, ... 65th Annual Meeting, 2018 | | 2018 |
9.3 Outcomes of Double-Blind RCT of Neurofeedback for ADHD LE Arnold, C Kerson, V Monastra, J Pan, H Kraemer, R Rice Jr, ... Journal of the American Academy of Child & Adolescent Psychiatry 57 (10), S283, 2018 | | 2018 |
Long-term outcomes in the Multimodal Treatment study of Children with ADHD (the MTA) JM Swanson, LE Arnold, PS Jensen, SP Hinshaw, LT Hechtman, ... Oxford textbook of attention deficit hyperactivity disorder, 315, 2018 | 28 | 2018 |